145 related articles for article (PubMed ID: 2279099)
1. [Effect of arginine-vasopressin on the rat thyroid gland in vitro].
Ditiateva GV; Krasnovskaia IA; Skopicheva VI
Biull Eksp Biol Med; 1990 Oct; 110(10):423-5. PubMed ID: 2279099
[TBL] [Abstract][Full Text] [Related]
2. [Morphofunctional characteristics of rat thyroid gland under the combined effect of oxytocin and adrenaline].
Makina DM; Krasnovskaia IA
Morfologiia; 1999; 115(1):34-7. PubMed ID: 10561851
[TBL] [Abstract][Full Text] [Related]
3. In vivo and in vitro effects of arginine-vasopressin receptor antagonists on the hypothalamic-pituitary-adrenal axis in the rat.
Bernardini R; Chiarenza A; Kamilaris TC; Renaud N; Lempereur L; Demitrack M; Gold PW; Chrousos GP
Neuroendocrinology; 1994 Nov; 60(5):503-8. PubMed ID: 7845540
[TBL] [Abstract][Full Text] [Related]
4. [Thyroid stimulating effect of exogenous vasopressin and oxytocin in hypophysectomized rats during immobilization stress].
Krasnovskaia IA; Sheĭbak TV
Biull Eksp Biol Med; 1990 Jan; 109(1):30-3. PubMed ID: 2334792
[TBL] [Abstract][Full Text] [Related]
5. Effects of prolonged administration of neurotensin, arginine-vasopressin, NPY, and bombesin on blood TSH, T3 and T4 levels in the rat.
Malendowicz LK; Miśkowiak B
In Vivo; 1990; 4(4):259-61. PubMed ID: 2103370
[TBL] [Abstract][Full Text] [Related]
6. Effects of arginine vasopressin (AVP) on the pituitary-thyroid axis in the rat: Evidence that endogenous AVP, acting via V1 receptors, lowers TSH blood concentration.
Malendowicz LK; Spinazzi R; Nowak KW; Nussdorfer GG; Majchrzak M
Int J Mol Med; 2004 Jun; 13(6):869-72. PubMed ID: 15138627
[TBL] [Abstract][Full Text] [Related]
7. [Molecular mechanisms of thyroid hormone synthesis and secretion].
Koibuchi N
Nihon Rinsho; 2012 Nov; 70(11):1844-8. PubMed ID: 23214051
[No Abstract] [Full Text] [Related]
8. Two distinct corticotrophin releasing activities of vasopressin.
Buckingham JC
Br J Pharmacol; 1985 Jan; 84(1):213-9. PubMed ID: 2983801
[TBL] [Abstract][Full Text] [Related]
9. Possible importance of thyroidal iodine compartments in the adaptation of thyroid hormone secretion to antithyroid drugs.
Studer H; Kohler H; Bürgi H; Binswanger C; Steiger J
Endocrinology; 1972 Nov; 91(5):1154-9. PubMed ID: 5072796
[No Abstract] [Full Text] [Related]
10. Detailed kinetic analysis of adrenocorticotropin secretion by dispersed rat anterior pituitary cells in a microperifusion system: effects of ovine corticotropin-releasing factor and arginine vasopressin.
Watanabe T; Orth DN
Endocrinology; 1987 Sep; 121(3):1133-45. PubMed ID: 3040378
[TBL] [Abstract][Full Text] [Related]
11. Central modulation of immunoreactive corticotropin-releasing factor secretion by arginine vasopressin.
Plotsky PM; Bruhn TO; Vale W
Endocrinology; 1984 Oct; 115(4):1639-41. PubMed ID: 6332731
[TBL] [Abstract][Full Text] [Related]
12. Antigen-presenting dendritic cells as regulators of the growth of thyrocytes: a role of interleukin-1beta and interleukin-6.
Simons PJ; Delemarre FG; Drexhage HA
Endocrinology; 1998 Jul; 139(7):3148-56. PubMed ID: 9645688
[TBL] [Abstract][Full Text] [Related]
13. Thyroid organotypic rat and human cultures used to investigate drug effects on thyroid function, hormone synthesis and release pathways.
Vickers AE; Heale J; Sinclair JR; Morris S; Rowe JM; Fisher RL
Toxicol Appl Pharmacol; 2012 Apr; 260(1):81-8. PubMed ID: 22342233
[TBL] [Abstract][Full Text] [Related]
14. TSH and dibutyryl-cyclic-AMP stimulation of hormone release from rat thyroid glands in vitro.
Tonoue T; Tong W; Stolc V
Endocrinology; 1970 Feb; 86(2):271-7. PubMed ID: 4188327
[No Abstract] [Full Text] [Related]
15. The effect of arginine vasopressin on ureagenesis in isolated rat hepatocytes.
Drew PJ; Monson JP; Metcalfe HK; Evans SJ; Iles RA; Cohen RD
Clin Sci (Lond); 1985 Aug; 69(2):231-3. PubMed ID: 4064567
[TBL] [Abstract][Full Text] [Related]
16. [Effect of lithium chloride on the thyroid gland of white rats].
Glumova VA; Petrov NM; Markov VN
Biull Eksp Biol Med; 1979 Jun; 87(6):604-7. PubMed ID: 465698
[TBL] [Abstract][Full Text] [Related]
17. Studies of the nature of the interaction between vasopressin and corticotropin-releasing factor on adrenocorticotropin release in the rat.
Rivier C; Rivier J; Mormede P; Vale W
Endocrinology; 1984 Sep; 115(3):882-6. PubMed ID: 6086290
[TBL] [Abstract][Full Text] [Related]
18. A two-step mechanism by which corticotropin-releasing hormone releases hypothalamic beta-endorphin: the role of vasopressin and G-proteins.
Burns G; Almeida OF; Passarelli F; Herz A
Endocrinology; 1989 Sep; 125(3):1365-72. PubMed ID: 2527150
[TBL] [Abstract][Full Text] [Related]
19. Research paper effects of 13-HPODE on expression of genes involved in thyroid hormone synthesis, iodide uptake and formation of hydrogen peroxide in porcine thyrocytes.
Luci S; Bettzieche A; Brandsch C; Eder K
Int J Vitam Nutr Res; 2006 Nov; 76(6):398-406. PubMed ID: 17607960
[TBL] [Abstract][Full Text] [Related]
20. Influence of nitric oxide synthase inhibitors on the vasopressin-induced pituitary-adrenocortical activity and hypothalamic catecholamine levels.
Bugajski J; Gadek-Michalska A; Głód R; Borycz J
J Physiol Pharmacol; 1998 Dec; 49(4):617-26. PubMed ID: 10069702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
